With more than 700 employees in the United States, EMD Serono is a leader in the biotechnology market. Located in Rockland, Mass., the company specializes in the discovery and development of medicines that address significant unmet medical needs. Its products focus on specific therapeutic areas, such as reproductive health, neurology and metabolic endocrinology. EMD Serono develops pharmaceuticals for the treatment of multiple sclerosis, infertility, hormone deficiency in children and adults, human immunodeficiency virus-associated wasting and short bowel syndrome. The company markets approximately seven products in the U.S., including Gonal-f, Luveris, Ovidrel, Rebif, Saizen, Serostim and Zorbtive. It is part of Merck Serono, a world leader in biotechnological innovation. Merck Serono maintains additional research facilities in Switzerland and Italy.
Partial Data by Infogroup (c) 2024. All rights reserved.
Partial Data by Foursquare.